Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis. Toorop AA, Hogenboom L, Bloem K, Kocyigit M, et al. J Neurol Neurosurg Psychiatry 2023 Jan 24:jnnp-2022-330793.

Read + Share

Amedeo Smart

Independent Medical Education

Toorop AA, Hogenboom L, Bloem K, Kocyigit M, et al. Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis. J Neurol Neurosurg Psychiatry 2023 Jan 24:jnnp-2022-330793.
PMID: 36693720